Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 December 2007, Vol. 110, No. 13, pp. 4140-4141.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Screpanti, I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Screpanti, I.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

IMMUNOBIOLOGY

Comment on Navarro et al, page 4331

CMS links the tail

Isabella Screpanti

SAPIENZA UNIVERSITY OF ROME

In this issue of Blood, Navarro and colleagues report the first molecular evidence for a pT{alpha} intracellular adaptor involved in human pre-TCR (T-cell receptor) function.

Pre–T-cell receptor (TCR) triggers a number of signals that are crucial for sustaining the complex differentiation program of T lymphocytes. Research has shown that pre-TCR signaling is required for the induction of proliferation, TCRβ allelic exclusion, and transition from CD4CD8 to CD4+CD8+ thymocytes.1 In order to signal, TCRs need to be recruited to the cell surface; unlike {alpha}β and {gamma}{delta}TCR, pre-TCR localizes cells autonomously to membrane rafts of thymocytes, and its signaling is constitutive and ligand independent. Moreover, analysis of the function of different structural domains of pT{alpha}, carried out by overexpressing pT{alpha} mutant transgenes in pT{alpha}–/– mice, has demonstrated that a proline-rich motif included in the cytoplasmic tail of pT{alpha} is required for the function of pre-TCR.2 However, the adaptor protein(s) interacting with and allowing the constitutive targeting of pT{alpha}/pre-TCR to the membrane rafts have so far remained unidentified.

Navarro and colleagues now suggest that the polyproline-arginine sequence in the human pT{alpha} cytoplasmic tail interacts in vitro with SH3 domains of the CIN85/CMS family of adaptors and, notably, that only one of those adaptors, CMS, interacts in vivo with human pT{alpha}. In support of this interaction's physiologic relevance, the authors found that deletion of the pT{alpha} CIN85/CMS-binding motif impairs pre-TCR mediated Ca2+ mobilization and NFAT transcriptional activity. The authors therefore suggest that CMS may act as a scaffolding molecule and be required for propagation of pre-TCR signaling.

Pre-TCR signaling also controls pT{alpha} transcription, and we know that pre-TCR function should be shut down to allow full function of {alpha}βTCR.3 To this end, pre-TCR signaling may result in the arrest of pT{alpha} and the triggering of TCR{alpha} transcription. This, together with the higher pairing efficiency of TCRβ with TCR{alpha} rather than with pT{alpha}, may finally favor the switch from pre-TCR to the {alpha}βTCR expression, thus sustaining differentiation progression. Besides the arrest of pT{alpha} transcription, which certainly leads to decreased pre-TCR expression, attenuation of pre-TCR expression and function may also be due to induced/increased pT{alpha} degradation. Navarro et al show that the CMS C-terminus is able to associate with polymerized actin in the endocytic compartment, colocalizing with internalized pT{alpha} in its trafficking to lysosomes. Moreover, the observation that CMS is up-regulated in post-β selected CD4+CD8+ thymocytes further supports a physiological role for CMS in attenuating pre-TCR signaling.

Overall, the data from Navarro and colleagues seem to suggest that CMS represents a pivotal regulator of pre-TCR function, being able, via its SH3 domains, to link the cytoplasmic tail of pT{alpha} and favor amplification of pre-TCR signaling and, through its C-terminal region, to allow pT{alpha} degradation, thus driving signaling attenuation. Given the increasing evidence of the crucial role deregulated pre-TCR signaling plays in sustaining a number of oncogenic pathways involved in T-cell leukemogenesis, the identification of molecules directly involved in regulating the balance between activation and degradation of pre-TCR may help to design novel therapeutic strategies.

Footnotes

Conflict-of-interest disclosure: The author declares no competing financial interests. {blacksquare}

REFERENCES

  1. von Boehmer H. Unique features of the pre-T-cell receptor {alpha}-chain: not just a surrogate. Nat Rev Immunol 2005; 5:571–577.[CrossRef][Medline] [Order article via Infotrieve]

  2. Aifantis I, Borowski C, Gounari F, Lacorazza HD, Nikoloch-Zugich J, von Boehmer H. A critical role for the cytoplasmic tail of pT{alpha} in T lymphocyte development. Nat Immunol 2002; 3:483–488.[Medline] [Order article via Infotrieve]

  3. Yamasaki S and Saito T. Molecular basis for pre-TCR-mediated autonomous signaling. Trends Immunol 2007; 28:39–43.[CrossRef][Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Identification of CMS as a cytosolic adaptor of the human pT{alpha} chain involved in pre-TCR function
María N. Navarro, Gretel Nusspaumer, Patricia Fuentes, Sara González-García, Juan Alcain, and María L. Toribio
Blood 2007 110: 4331-4340. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Screpanti, I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Screpanti, I.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020